Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Mimedx (MDXG) Operating Margin (2016 - 2025)

Mimedx's Operating Margin history spans 15 years, with the latest figure at 17.85% for Q4 2025.

  • For Q4 2025, Operating Margin rose 595.0% year-over-year to 17.85%; the TTM value through Dec 2025 reached 15.26%, down 161.0%, while the annual FY2025 figure was 15.26%, 161.0% down from the prior year.
  • Operating Margin for Q4 2025 was 17.85% at Mimedx, down from 19.51% in the prior quarter.
  • Across five years, Operating Margin topped out at 26.89% in Q2 2024 and bottomed at 15.79% in Q1 2022.
  • The 5-year median for Operating Margin is 12.22% (2025), against an average of 6.73%.
  • The largest annual shift saw Operating Margin skyrocketed 2775bps in 2023 before it tumbled -1435bps in 2025.
  • A 5-year view of Operating Margin shows it stood at 2.53% in 2021, then surged by 501bps to 15.21% in 2022, then rose by 17bps to 17.84% in 2023, then tumbled by -33bps to 11.9% in 2024, then surged by 50bps to 17.85% in 2025.
  • Per Business Quant, the three most recent readings for MDXG's Operating Margin are 17.85% (Q4 2025), 19.51% (Q3 2025), and 12.55% (Q2 2025).